The impact of proposed changes to ICD-11 on estimates of PTSD prevalence and comorbidity

Blair E. Wisco; Mark W. Miller; Erika J. Wolf; Dean Kilpatrick; Heidi S. Resnick; Christal L. Badour; Brian P. Marx; Terence M. Keane; Raymond C. Rosen; Matthew J. Friedman

doi:10.1016/j.psychres.2016.04.043

The impact of proposed changes to ICD-11 on estimates of PTSD prevalence and comorbidity

Blair E. Wisco, Mark W. Miller, Erika J. Wolf, Dean Kilpatrick, Heidi S. Resnick, Christal L. Badour, Brian P. Marx, Terence M. Keane, Raymond C. Rosen, Matthew J. Friedman

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Abstract

The World Health Organization's posttraumatic stress disorder (PTSD) work group has published a proposal for the forthcoming edition of the International Classification of Diseases (ICD-11) that would yield a very different diagnosis relative to DSM-5. This study examined the impact of the proposed ICD-11 changes on PTSD prevalence relative to the ICD-10 and DSM-5 definitions and also evaluated the extent to which these changes would accomplish the stated aim of reducing the comorbidity associated with PTSD. Diagnostic prevalence estimates were compared using a U.S. national community sample and two U.S. Department of Veterans Affairs clinical samples. The ICD-11 definition yielded prevalence estimates 10-30% lower than DSM-5 and 25% and 50% lower than ICD-10 with no reduction in the prevalence of common comorbidities. Findings suggest that by constraining the diagnosis to a narrower set of symptoms, the proposed ICD-11 criteria set would substantially reduce the number of individuals with the disorder. These findings raise doubt about the extent to which the ICD-11 proposal would achieve the aim of reducing comorbidity associated with PTSD and highlight the public health and policy implications of such a redefinition.

Original language	English
Pages (from-to)	226-233
Number of pages	8
Journal	Psychiatry Research
Volume	240
DOIs	https://doi.org/10.1016/j.psychres.2016.04.043
State	Published - Jun 30 2016

Bibliographical note

Funding Information:
Data collection was funded by an American Psychiatric Association DSM grant to Dean Kilpatrick and the U.S. Department of Veterans Affairs . Manuscript preparation was supported by a VA Merit Review grant ( 5I01CX000431 ) awarded to Mark Miller, a VA Clinical Sciences Research and Development Program Career Development Award to Erika Wolf, funding from the National Institute of Mental Health ( 1R01MH095737-01A1 ), U.S. Department of Defense ( W81XWH-12-2-0117-PTSD-IIRA-INT ), Defense Advanced Research Programs Agency ( N66001-11-C-4006 ) and U.S. Department of Veterans Affairs (Cooperative Studies Program # 591 ) awarded to Dr. Marx, and funding from the U.S. Department of Defense ( W81XWH-10-2-0181 ) awarded to Drs. Marx and Keane. The authors have no conflicts of interest to report. Drs. Friedman and Kilpatrick served on the Trauma/Stressor-Related and Dissociative Disorders Sub-Work Group of the Anxiety Disorder Work Group of DSM-5 . Contents are solely the responsibility of the authors and views expressed do not represent those of the APA, the U.S. Department of Veterans Affairs, the U.S. Government, or other agencies supporting this research.

Publisher Copyright:
© 2016.

Keywords

DSM-5
Diagnosis
Diagnostic criteria
ICD-11
PTSD
Trauma

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.psychres.2016.04.043

Cite this

@article{93b4a853fb564c10be2e8689885b7c23,

title = "The impact of proposed changes to ICD-11 on estimates of PTSD prevalence and comorbidity",

abstract = "The World Health Organization's posttraumatic stress disorder (PTSD) work group has published a proposal for the forthcoming edition of the International Classification of Diseases (ICD-11) that would yield a very different diagnosis relative to DSM-5. This study examined the impact of the proposed ICD-11 changes on PTSD prevalence relative to the ICD-10 and DSM-5 definitions and also evaluated the extent to which these changes would accomplish the stated aim of reducing the comorbidity associated with PTSD. Diagnostic prevalence estimates were compared using a U.S. national community sample and two U.S. Department of Veterans Affairs clinical samples. The ICD-11 definition yielded prevalence estimates 10-30% lower than DSM-5 and 25% and 50% lower than ICD-10 with no reduction in the prevalence of common comorbidities. Findings suggest that by constraining the diagnosis to a narrower set of symptoms, the proposed ICD-11 criteria set would substantially reduce the number of individuals with the disorder. These findings raise doubt about the extent to which the ICD-11 proposal would achieve the aim of reducing comorbidity associated with PTSD and highlight the public health and policy implications of such a redefinition.",

keywords = "DSM-5, Diagnosis, Diagnostic criteria, ICD-11, PTSD, Trauma",

author = "Wisco, {Blair E.} and Miller, {Mark W.} and Wolf, {Erika J.} and Dean Kilpatrick and Resnick, {Heidi S.} and Badour, {Christal L.} and Marx, {Brian P.} and Keane, {Terence M.} and Rosen, {Raymond C.} and Friedman, {Matthew J.}",

note = "Funding Information: Data collection was funded by an American Psychiatric Association DSM grant to Dean Kilpatrick and the U.S. Department of Veterans Affairs . Manuscript preparation was supported by a VA Merit Review grant ( 5I01CX000431 ) awarded to Mark Miller, a VA Clinical Sciences Research and Development Program Career Development Award to Erika Wolf, funding from the National Institute of Mental Health ( 1R01MH095737-01A1 ), U.S. Department of Defense ( W81XWH-12-2-0117-PTSD-IIRA-INT ), Defense Advanced Research Programs Agency ( N66001-11-C-4006 ) and U.S. Department of Veterans Affairs (Cooperative Studies Program # 591 ) awarded to Dr. Marx, and funding from the U.S. Department of Defense ( W81XWH-10-2-0181 ) awarded to Drs. Marx and Keane. The authors have no conflicts of interest to report. Drs. Friedman and Kilpatrick served on the Trauma/Stressor-Related and Dissociative Disorders Sub-Work Group of the Anxiety Disorder Work Group of DSM-5 . Contents are solely the responsibility of the authors and views expressed do not represent those of the APA, the U.S. Department of Veterans Affairs, the U.S. Government, or other agencies supporting this research. Publisher Copyright: {\textcopyright} 2016.",

year = "2016",

month = jun,

day = "30",

doi = "10.1016/j.psychres.2016.04.043",

language = "English",

volume = "240",

pages = "226--233",

}

TY - JOUR

T1 - The impact of proposed changes to ICD-11 on estimates of PTSD prevalence and comorbidity

AU - Wisco, Blair E.

AU - Miller, Mark W.

AU - Wolf, Erika J.

AU - Kilpatrick, Dean

AU - Resnick, Heidi S.

AU - Badour, Christal L.

AU - Marx, Brian P.

AU - Keane, Terence M.

AU - Rosen, Raymond C.

AU - Friedman, Matthew J.

N1 - Funding Information: Data collection was funded by an American Psychiatric Association DSM grant to Dean Kilpatrick and the U.S. Department of Veterans Affairs . Manuscript preparation was supported by a VA Merit Review grant ( 5I01CX000431 ) awarded to Mark Miller, a VA Clinical Sciences Research and Development Program Career Development Award to Erika Wolf, funding from the National Institute of Mental Health ( 1R01MH095737-01A1 ), U.S. Department of Defense ( W81XWH-12-2-0117-PTSD-IIRA-INT ), Defense Advanced Research Programs Agency ( N66001-11-C-4006 ) and U.S. Department of Veterans Affairs (Cooperative Studies Program # 591 ) awarded to Dr. Marx, and funding from the U.S. Department of Defense ( W81XWH-10-2-0181 ) awarded to Drs. Marx and Keane. The authors have no conflicts of interest to report. Drs. Friedman and Kilpatrick served on the Trauma/Stressor-Related and Dissociative Disorders Sub-Work Group of the Anxiety Disorder Work Group of DSM-5 . Contents are solely the responsibility of the authors and views expressed do not represent those of the APA, the U.S. Department of Veterans Affairs, the U.S. Government, or other agencies supporting this research. Publisher Copyright: © 2016.

PY - 2016/6/30

Y1 - 2016/6/30

N2 - The World Health Organization's posttraumatic stress disorder (PTSD) work group has published a proposal for the forthcoming edition of the International Classification of Diseases (ICD-11) that would yield a very different diagnosis relative to DSM-5. This study examined the impact of the proposed ICD-11 changes on PTSD prevalence relative to the ICD-10 and DSM-5 definitions and also evaluated the extent to which these changes would accomplish the stated aim of reducing the comorbidity associated with PTSD. Diagnostic prevalence estimates were compared using a U.S. national community sample and two U.S. Department of Veterans Affairs clinical samples. The ICD-11 definition yielded prevalence estimates 10-30% lower than DSM-5 and 25% and 50% lower than ICD-10 with no reduction in the prevalence of common comorbidities. Findings suggest that by constraining the diagnosis to a narrower set of symptoms, the proposed ICD-11 criteria set would substantially reduce the number of individuals with the disorder. These findings raise doubt about the extent to which the ICD-11 proposal would achieve the aim of reducing comorbidity associated with PTSD and highlight the public health and policy implications of such a redefinition.

AB - The World Health Organization's posttraumatic stress disorder (PTSD) work group has published a proposal for the forthcoming edition of the International Classification of Diseases (ICD-11) that would yield a very different diagnosis relative to DSM-5. This study examined the impact of the proposed ICD-11 changes on PTSD prevalence relative to the ICD-10 and DSM-5 definitions and also evaluated the extent to which these changes would accomplish the stated aim of reducing the comorbidity associated with PTSD. Diagnostic prevalence estimates were compared using a U.S. national community sample and two U.S. Department of Veterans Affairs clinical samples. The ICD-11 definition yielded prevalence estimates 10-30% lower than DSM-5 and 25% and 50% lower than ICD-10 with no reduction in the prevalence of common comorbidities. Findings suggest that by constraining the diagnosis to a narrower set of symptoms, the proposed ICD-11 criteria set would substantially reduce the number of individuals with the disorder. These findings raise doubt about the extent to which the ICD-11 proposal would achieve the aim of reducing comorbidity associated with PTSD and highlight the public health and policy implications of such a redefinition.

KW - DSM-5

KW - Diagnosis

KW - Diagnostic criteria

KW - ICD-11

KW - PTSD

KW - Trauma

UR - http://www.scopus.com/inward/record.url?scp=84964336317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964336317&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2016.04.043

DO - 10.1016/j.psychres.2016.04.043

M3 - Article

C2 - 27124207

AN - SCOPUS:84964336317

VL - 240

SP - 226

EP - 233

ER -

The impact of proposed changes to ICD-11 on estimates of PTSD prevalence and comorbidity

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this